Mesothelin expression as a predictive biomarker of breast cancer outcomes.

11119 Background: Mesothelin, previously-shown to be expressed in triple negative breast cancer (TNBC) tumors, is a potential therapeutic target and prognostic marker in breast cancer. Methods: We ...